[{"id":"6197c2dd-dcac-48ae-964b-1bb53f9a93dc","acronym":"FOG-001-101","url":"https://clinicaltrials.gov/study/NCT05919264","created_at":"2023-06-26T14:09:21.574Z","updated_at":"2024-07-02T16:34:36.852Z","phase":"Phase 1/2","brief_title":"FOG-001 in Locally Advanced or Metastatic Solid Tumors","source_id_and_acronym":"NCT05919264 - FOG-001-101","lead_sponsor":"Fog Pharmaceuticals, Inc.","biomarkers":" MSI • CTNNB1","pipe":" | ","alterations":" MYC expression","tags":["MSI • CTNNB1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYC expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e zolucatetide (FOG-001)"],"overall_status":"Recruiting","enrollment":" Enrollment 245","initiation":"Initiation: 05/19/2023","start_date":" 05/19/2023","primary_txt":" Primary completion: 04/01/2027","primary_completion_date":" 04/01/2027","study_txt":" Completion: 08/31/2027","study_completion_date":" 08/31/2027","last_update_posted":"2024-06-10"}]